OBJECTIVES: The objectives were to study diagnostic means, therapeutic methods and their results at the two university hospitals in LOME. METHODS: It is about descriptive retrospective study carry out at Tokoin and Campus hospitals, from 1st January 1990 to 31 December 1999 (10 years). Patients were chosen on the histological proof. RESULTS: With 63 cases colliged in 10 years on 104 cancers of digestive tract, gastric cancer occupped the uppermost (60.6%) in digestive cancers. Sex-ratio was 1.7 and average age of the patients was 52, 6 years old with extreme of 20 and 85 years old. The clinic was dominated by abdominal pains (71.4%). Vegetative ulcerous (50%) and ulcerous (21.7%) lesions were the most frequent with a predominance of pyloric antrum localisation (71.7%). Adenocarcinoma was histologic type frequently refound (87.3%). On the therapeutic way 29 patients have benefited surgical treatment, 46% of operability. Resection rate was 32% and palliative treatment was 51.7%. The postoperative mortality rate was 13.8%. CONCLUSION: Gastric cancer prognosis remain bad with a survival of 7% in one year and 21% in 3 months.
OBJECTIVES: The objectives were to study diagnostic means, therapeutic methods and their results at the two university hospitals in LOME. METHODS: It is about descriptive retrospective study carry out at Tokoin and Campus hospitals, from 1st January 1990 to 31 December 1999 (10 years). Patients were chosen on the histological proof. RESULTS: With 63 cases colliged in 10 years on 104 cancers of digestive tract, gastric cancer occupped the uppermost (60.6%) in digestive cancers. Sex-ratio was 1.7 and average age of the patients was 52, 6 years old with extreme of 20 and 85 years old. The clinic was dominated by abdominal pains (71.4%). Vegetative ulcerous (50%) and ulcerous (21.7%) lesions were the most frequent with a predominance of pyloric antrum localisation (71.7%). Adenocarcinoma was histologic type frequently refound (87.3%). On the therapeutic way 29 patients have benefited surgical treatment, 46% of operability. Resection rate was 32% and palliative treatment was 51.7%. The postoperative mortality rate was 13.8%. CONCLUSION:Gastric cancer prognosis remain bad with a survival of 7% in one year and 21% in 3 months.